Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

Steven Hochwald, MD, FACS

  • Esophageal Cancer Research Fund. Steven Hochwald (Principal Investigator). Roswell Park Cancer Institute. $400,000. 2/1/2013-1/1/2017.

Fumito Ito, MD, PhD

  • Roswell Park Alliance Foundation Grant. Fumito Ito (Principal Investigator). Roswell Park Alliance Foundation. $100,000. 1/1/2019-12/1/2020.
  • Roswell Park Alliance Foundation Grant. Fumito Ito (Principal Investigator). Roswell Park Alliance Foundation. $127,500. 3/1/2018-2/1/2019.
  • Sarcoma Foundation of America Award. Fumito Ito (Principal Investigator). Sarcoma Foundation of America. $50,000. 7/1/2017-6/1/2018.
  • NIH/NCI K08 Mentored Clinical Scientist Research Career Development Award. Fumito Ito (Principal Investigator). NIH/NCI. $810,000. 8/1/2015-7/1/2020.
  • Melanoma Research Alliance Young Investigator Award. Fumito Ito (Principal Investigator). Melanoma Research Alliance. $225,000. 5/1/2015-4/1/2018.

Steven Schwaitzberg, MD

  • Develop virtual simulation of tissue energy interactions. Steven Schwaitzberg (Co-Investigator). National Institute of Health. 1/1/2012-1/1/2017.

Kazuaki Takabe, MD, PhD, FACS

  • Role of Tumor &/or Host Sphingosine-1-Phosphate in Hem-&lymphangiogenesis. Kazuaki Takabe (Principal Investigator). Susan G. Komen. $180,000. 12/1/2015-11/1/2020.
  • Bile Acid and Sphingosine -1- phosphate Receptor-mediated Signaling in Cholestasis. Kazuaki Takabe (Co-Investigator). NIH/National Institute of Digestive Disease and Kidney. $37,475. 12/1/2015-11/1/2020.
  • Sphingosine-1-phosphate in breast cancer progression and lymphangiogenesis. Kazuaki Takabe (Principal Investigator). NIH/National Cancer Institute TME. $1,008,785. 7/1/2012-4/1/2017.